Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Sorry about the malfunction . THEN WHO
I believe that DP has stated that both he and Turley are presenting to analysts. Management has accomplished a lot of goals in the past year and hopefully will attain another by becoming listed on the NASDAQ. But prior to that they are going to have to be able to purchase 3 million shares and have the amount of shares outstanding decrease by 3 million rather than increase by 20 million.
Share
New Message
Please login to post a reply